where do i give myself the semaglutide shot INJECTION How to inject semaglutide for

Another person in this space, bestselling author Dr

Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials

Key Takeaway: Dosage is not a competition

to correct both the hyperglycemia and the metabolic derangement causing ketoacidosis Hyperosmolar hyperglycemic non-ketotic state in Type 2 diabetes Infections and poor wound healing in all diabetics In type 2 diabetes complications are present in approximately 50% of patients at the time of diagnosis

Common side effects associated with retatrutide consistent with the broader GLP-1 receptor agonist class, as described in the Summary of Product Characteristics (SmPC) for licensed medicines such as Wegovy (semaglutide 2.4 mg) and Mounjaro (tirzepatide) include: Nausea (particularly during dose escalation) Vomiting Diarrhoea or constipation Decreased appetite Injection site reactions such as mild redness or discomfort Increased heart rate , which has been observed with incretin-based therapies These gastrointestinal effects are typically most pronounced when starting treatment or increasing the dose, and they often improve over time as the body adjusts